Gd- Minimising Dose Without Jeopardising Diagnosis
Susie Huang1
1Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Synopsis
The
safety of gadolinium (Gd) continues to be questioned as concerns grow around gadolinium
deposition in the brain and body. This lecture examines strategies for
minimizing the dose of gadolinium in clinical practice without compromising
diagnosis and management. The presentation will provide an overview of current
approaches to avoid or decrease the use of gadolinium in the context of the
clinical question that is posed. Emerging techniques for minimizing, if not
eliminating, gadolinium will be discussed, and an outlook on the future of
gadolinium usage in clinical examinations will be provided.
Learning Objectives
- Identify the perceived risks associated
with gadolinium-based contrast agents.
- Identify current strategies for
minimizing gadolinium dose in the context of clinical indication, technical
solutions, and diagnostic necessity.
- Demonstrate the value of established and
emerging techniques for minimizing gadolinium dose.
Summary
The
safety of gadolinium (Gd) continues to be questioned as concerns grow around gadolinium
deposition in the brain and body. This lecture examines strategies for
minimizing the dose of gadolinium in clinical practice without compromising
diagnosis and management. The presentation will provide an overview of current
approaches to avoid or decrease the use of gadolinium in the context of the
clinical question that is posed. Emerging techniques for minimizing, if not
eliminating, gadolinium will be discussed, and an outlook on the future of
gadolinium usage in clinical examinations will be provided.Acknowledgements
No acknowledgement found.References
No reference found.
Proc. Intl. Soc. Mag. Reson. Med. 28 (2020)